Back
Design Therapeutics Stock Price Chart
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Buy
52
DSGN
Design Therapeutics
Last Price:
5.62
Seasonality Move:
-24.36%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing slight selling pressure.
Design Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.16 | Buy |
| 20-day SMA: | 4.99 | Buy |
| 50-day SMA: | 4.61 | Buy |
| 200-day SMA: | 3.53 | Buy |
| 8-day EMA: | 5.28 | Buy |
| 20-day EMA: | 5 | Buy |
| 50-day EMA: | 4.65 | Buy |
| 200-day EMA: | 4.15 | Buy |
Design Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 59.84 | Buy |
| Chaikin Money Flow: | -33588 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.42 - 5.28) | Buy |
| Bollinger Bands (100): | (3.64 - 4.86) | Buy |
Design Therapeutics Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics Stock
Is Design Therapeutics Stock a Buy?
- Design Therapeutics share price is 5.54 while DSGN 8-day simple moving average is 5.16, which is a Buy signal.
- The stock price of DSGN is 5.54 while Design Therapeutics 20-day SMA is 4.99, which makes it a Buy.
- Design Therapeutics 50-day simple moving average is 4.61 while DSGN share price is 5.54, making it a Buy technically.
- DSGN stock price is 5.54 and Design Therapeutics 200-day simple moving average is 3.53, creating a Buy signal.
DSGN Technical Analysis vs Fundamental Analysis
Buy
52
Design Therapeutics (DSGN)
is a Buy
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a Buy
The current Design Therapeutics [DSGN] share price is $5.54. The Score for DSGN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Design Therapeutics Stock Info
Market Cap:
313.68M
Price in USD:
5.54
Share Volume:
291.08K
Design Therapeutics 52-Week Range
52-Week High:
6.91
52-Week Low:
1.96
Buy
52
Design Therapeutics (DSGN)
is a Buy
Design Therapeutics Share Price Forecast
-
What is the Design Therapeutics stock price today?
The Design Therapeutics stock price is 5.54 USD today. -
Will DSGN stock go up or go down?
Design Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Design Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics is not overvalued.
Is Design Therapeutics Stock a Buy?
- Design Therapeutics share price is 5.54 while DSGN 8-day exponential moving average is 5.28, which is a Buy signal.
- The stock price of DSGN is 5.54 while Design Therapeutics 20-day EMA is 5.00, which makes it a Buy.
- Design Therapeutics 50-day exponential moving average is 4.65 while DSGN share price is 5.54, making it a Buy technically.
- DSGN stock price is 5.54 and Design Therapeutics 200-day simple moving average is 4.15, creating a Buy signal.
Fundamental Analysis of Design Therapeutics
Is Design Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.
Technical Analysis of Design Therapeutics
Should I short Design Therapeutics stock?
- DSGN Moving Average Covergence Divergence (MACD) indicator is 0.25, suggesting Design Therapeutics is a Buy
- Design Therapeutics Relative Strength Index (RSI) is 59.84, which suggest Design Therapeutics is overbought
- The Bollinger Bands (25) for Design Therapeutics is (4.42 - 5.28), which suggest Design Therapeutics is a Buy
- The Bollinger Bands (100) for Design Therapeutics is (3.64 - 4.86), which suggest Design Therapeutics is a Buy
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.